| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |